GILD insider trades & Congress trades
Gilead Sciences, Inc.: public insider filings and Congress disclosures, in one place.
Bourse has recorded 2 open-market insider transactions in Gilead Sciences, Inc. (GILD) (0 purchases with code P and 2 sales with code S), the most recent on October 15, 2026.
In the last 90 days: 0 purchases by 0 insiders ($0) and 2 sales by 2 ($937K).
Members of Congress have disclosed 1 trades in GILD (0 purchases, 1 sales), the latest transaction dated August 10, 2026. Congress filings can arrive up to 45 days after the trade.
Insider transactions
SEC Form 4, open-market purchases (P) and sales (S) only. Awards, option exercises and tax withholding are excluded. “After” shows the stock’s return over the month following the trade, where available.
| Date | Insider | Role | Type | Shares | Price | Value | After 1M |
|---|---|---|---|---|---|---|---|
| Oct 15, 2026 | Mercier Johanna | Chief Comm & Corp Aff Officer | Sell | 3,000 | $156.22 | $469K | – |
| Oct 15, 2026 | Dickinson Andrew D | Chief Financial Officer | Sell | 3,000 | $156.22 | $469K | – |
Congress trades
Disclosures under the STOCK Act. Amounts are reported as ranges; some trades are made by a spouse or dependent child.
| Traded | Member | Party | Type | Amount | Disclosed | Filing |
|---|---|---|---|---|---|---|
| Aug 10, 2026 | Rohit Khanna | house | Sell | $1,001 - $15,000 | Sep 4, 2026 | – |
Data as of October 22, 2026. Public filings only. A purchase or sale by a politician or an insider does not by itself imply any wrongdoing.
New to these filings? Read how to read a Form 4, how Congress trades are disclosed and what insider cluster buying means. Sources and limits are on the Methodology page.
See these filings as they land
Bourse collects Congress trades, SEC Form 4 insider filings and 13F fund holdings in one live feed, and flags insider buying clusters automatically. Free to start.
Bourse provides financial data and editorial information, parts of which are generated by AI. This page is for general education only. It is not personalised investment advice or a recommendation to buy or sell any financial instrument. Make your own decisions.